Cancer Drugs
Lynparza
Also known as: Olaparib, PARP inhibitor
Definition
Olaparib, a PARP inhibitor for BRCA-mutated ovarian, breast, pancreatic, and prostate cancers.
Detailed Explanation
Lynparza exploits synthetic lethality in tumors with homologous recombination deficiency. Used as maintenance after platinum response or in metastatic settings.